As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Nice Insight’s Top Companies lists are comprised of the highest scoring companies, as rated by buyers of outsourced services, with respect to customer perception within each category. Customer perception describes how a current buyer or prospect rates a company based on the information they have been exposed to—from marketing materials to word-of-mouth influence, as well as experience with the company. Nice Insight uses six key drivers of outsourcing—quality, reliability, productivity, affordability, innovation and regulatory history—to measure customer perception; the number listed is the average of the six individual scores, down to the decimal point.
CRO Preclinical
| Analytical Services | Overall CP | |
|---|---|---|
| 1 | Eurofins Lancaster | 92.80% |
| 2 | Surpass | 90.00% |
| 3 | Huntingdon Life Sciences | 89.13% |
| 4 | Frontage | 88.33% |
| 5 | QPS | 87.17% |
| 6 | BASi | 87.00% |
| 6 | Sannova Analytical | 87.00% |
| 8 | Product Safety Labs | 86.00% |
| 9 | Algorithme | 85.50% |
| 10 | Covance | 85.40% |
| 10 | Quintiles | 85.40% |
| BioAnalytical Services | Overall CP | |
|---|---|---|
| 1 | Product Safety Labs | 93.37% |
| 2 | Ricerca | 92.83% |
| 3 | Covance | 90.57% |
| 4 | Frontage | 90.00% |
| 5 | Charles River | 89.53% |
| 6 | QPS | 89.33% |
| 7 | Eurofins Lancaster | 88.90% |
| 8 | Huntingdon Life Sciences | 88.33% |
| 9 | Worldwide Clinical Trials | 87.63% |
| 10 | Seventh Wave | 87.57% |
| 10 | Sannova Analytical | 87.57% |
| Toxicology | Overall CP | |
|---|---|---|
| 1 | Sannova Analytical | 88.33% |
| 2 | Huntingdon Life Sciences | 87.20% |
| 3 | BASi | 86.67% |
| 4 | Frontage | 85.73% |
| 5 | Toxikon | 85.53% |
| 6 | MicroConstants | 84.30% |
| 7 | BRI | 81.67% |
| 7 | SNBL | 81.67% |
| 9 | Product Safety Labs | 81.33% |
| 10 | QPS | 81.00% |
| Pharmacovigilance | Overall CP | |
|---|---|---|
| 1 | Worldwide Clinical Trials | 90.00% |
| 2 | Quintiles | 87.50% |
| 3 | Huntingdon Life Sciences | 86.67% |
| 4 | MPI Research | 82.00% |
| 5 | Algorithme | 81.13% |
| 6 | Frontage | 81.11% |
| 6 | SNBL | 81.11% |
| 8 | Tandem Labs | 80.56% |
| 9 | QPS | 79.33% |
| 10 | Charles River | 78.06% |
| Analytical Services | Overall CP | |
|---|---|---|
| 1 | Eurofins Lancaster | 92.80% |
| 2 | Clinlogix | 89.63% |
| 3 | SGS | 89.20% |
| 4 | Frontage | 88.33% |
| 5 | QPS | 87.17% |
| 6 | Sannova Analytical | 87.00% |
| 7 | Chiltern | 86.70% |
| 8 | Parexel | 86.40% |
| 9 | PPD | 85.86% |
| 10 | Covance | 85.40% |
| 10 | Quintiles | 85.40% |
| BioAnalytical Services | Overall CP | |
|---|---|---|
| 1 | Covance | 90.56% |
| 2 | Frontage | 90.00% |
| 2 | SGS | 90.00% |
| 4 | Charles River | 89.53% |
| 5 | QPS | 89.33% |
| 6 | Eurofins Lancaster | 88.90% |
| 7 | Clinlogix | 88.33% |
| 8 | CNS | 88.00% |
| 9 | Worldwide Clinical Trials | 87.63% |
| 10 | Sannova Analytical | 87.56% |
| Clinical Monitoring | Overall CP | |
|---|---|---|
| 1 | Clinlogix | 89.06% |
| 2 | Parexel | 86.67% |
| 3 | PRA | 86.33% |
| 4 | Celerion | 85.46% |
| 5 | Rho | 85.13% |
| 6 | Medsource | 84.83% |
| 7 | QPS | 84.33% |
| 8 | SynteractHCR | 84.03% |
| 9 | SNBL | 84.00% |
| 10 | Novotech | 83.83% |
| Clinical Research | Overall CP | |
|---|---|---|
| 1 | INC Research | 93.33% |
| 2 | Parexel | 85.97% |
| 3 | Celerion | 85.83% |
| 4 | Intertek | 85.30% |
| 5 | Clinlogix | 84.90% |
| 6 | Vince & Associates | 83.30% |
| 7 | Bioskin | 83.00% |
| 8 | InnoPharma | 82.83% |
| 9 | SanaClis | 82.80% |
| 10 | SGS | 82.26% |
Relevant
news
marketing@medicilon.com
ABOUT
